Allelic imbalance at 11q23-q24 chromosome associated with estrogen and radiation-induced breast cancer progression

International Journal of Oncology

Volumn 28, Issue 3, 2006, Pages 667-674

  Roy, Debasish ^a   Calaf, G M ^a,b   Hande, M P ^c   Hei, T K ^a  

^a Columbia University ^*  (United States)

^b UNIVERSIDAD DE TARAPACÁ   (Chile)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Allelic imbalance; Breast cancer; Estrogen

Indexed keywords

ESTROGEN; MICROSATELLITE DNA;

ALPHA RADIATION; ARTICLE; BREAST TUMOR; CELL LINE; CELL TRANSFORMATION; CHROMOSOME 11; DRUG EFFECT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METHODOLOGY; PATHOLOGY; RADIATION EXPOSURE; TUMOR CELL LINE;

ALPHA PARTICLES; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 11; ESTROGENS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS;

EID: 33645216988     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.3.667     Document Type: Article

References (58)

1. Vogelstein B and Kinzler KW: The multistep nature of cancer. Trends Genet 9: 138-141, 1993.
2. Friend SH, Dryja TP and Weinberg RA: Oncogenes and tumor suppressing genes. N Engl J Med 318: 618-622, 1988.
3. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184-7189, 1990.
4. Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I and Cavenee WK: Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55: 2660-2664, 1995.
5. Lasko D, Cavenee W and Nordenskjold M: Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25: 281-314, 1991.
6. Nowell PC: Cancer chromosomes and genes. Lab Invest 66: 407-417, 1992.
7. Miller BA, Ries LAG, Hankey BF, Kosary CL and Edwards BK: Cancer statistics review: 1973-1989. Bethesda, MD, NCI; NIH Publication no. 92-2789, 1992.
8. Berg JW and Hutter RVP: Breast cancer. Cancer 75 (Suppl 1): 257-269, 1995.
9. Nowell PC: The clonal evolution of tumor cell populations. Science 194: 23-28, 1976.
10. Cheng KC and Loeb LA: Genomic instability and tumor progression: mechanistic considerations. Adv Cancer Res 60: 121-156, 1993.
11. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL and Cornelisse CJ: At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5: 554-560, 1989.
12. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM and Borresen AL: Genetic alterations of the tumor suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer 4: 113-121, 1992.
13. Anderson RM, Marsden SJ, Paice SJ, Bristow AE, Kadhim MA, Griffin CS and Goodhead DT: Transmissible and nontransmissible complex chromosome aberrations characterized by three-color and mFISH define a biomarker of exposure to high-LET alpha particles. Radiat Res 159: 40-48, 2003.
14. Speicher MR, Gwyn Ballard SG and Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12: 368-375, 1996. (Pubitemid 26105926)
15. Park CC, Henshall-Powell RL, Erickson AC, Talhouk R, Parvin B, Bissell MJ and Barcellos-Hoff MH: Ionizing radiation induces heritable disruption of epithelial cell interactions. Proc Natl Acad Sci USA 100: 10728-10733, 2003. (Pubitemid 37140096)
16. Grosovsky AJ: Radiation-induced mutations in unirradiated DNA. Proc Natl Acad Sci USA 96: 5346-5347, 1999.
17. Carter SL, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF and Croce CM: Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54: 6270-6274, 1994.
18. Kollias J, Man S, Marafie M, Carpenter K, Pinder S, Ellis IO, Blamey RW, Cross G and Brook JD: Loss of heterozygosity in bilateral breast cancer. Breast Cancer Res Treat 64: 241-251, 2000.
19. Tomlinson IP, Nicolai H, Solomon E and Bodmer WF: The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J Pathol 180: 38-43, 1996.
20. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brodano G and Croce CM: Suppression of tumorigenecity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosome 6 and 11. Cancer Res 54: 1331-1336, 1994.
21. Rasio D, Negrini M, Manenti G, Dragani T and Croce CM: Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res 55: 3988-3991, 1995.
22. Davis M, Hitchcock A, Foulkes WD and Campbell IG: Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56: 741-744, 1996.
23. Lee AS, Seo YC, Chang A, Tohari S, Eu KW, Seow-Choen F and McGee JO: Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma. Br J Cancer 83: 750-755, 2000.
24. Calaf G and Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492, 1993.
25. Calaf G, Zhang PL, Alvarado ME, Estrada S and Russo J: c-Haras oncogene enhances the neoplastic transformation of human breast epithelial cells treated with chemical carcinogens. Int J Oncol 6: 5-11, 1995.
26. National Research Council, Committee on the Biological Effects of Ionizing Radiation, Health Effects of Exposure to Radon (BEIR VI). National Academy Press, Washington, DC, 1998.
27. Anderson RM, Stevens DL and Goodhead DT: M-FISH analysis shows that complex chromosome aberrations induced by •-particle tracks are cumulative products of localized rearrangements. Proc Natl Acad Sci USA 99: 12167-12172, 2002.
28. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB and Zaider M: Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 100: 13761-13766, 2003.
29. Goodhead DT: Track structure considerations in low-dose and low-dose rate effects of ionizing-radiation. Adv Radiat Biol 16: 7-44, 1992.
30. Calaf G and Hei TK: Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis 21: 769-776, 2000. (Pubitemid 30214035)
31. Roy D, Calaf G and Hei TK: Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells. Carcinogenesis 22: 1685-1692, 2001. (Pubitemid 32952148)
32. Roy D, Calaf G and Hei TK: Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int J Cancer 103: 730-737, 2003.
33. Roy D, Calaf G and Hei TK: Profiling of differentially expressed genes induced by high linear energy transfer radiation in breast epithelial cells. Mol Carcinog 31: 192-203, 2001.
34. Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation. Int J Radiat Biol 77: 31-40, 2001. (Pubitemid 32096694)
35. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ and Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990. (Pubitemid 20331424)
36. Calaf G, Russo J, Tait L, Estrada S and Alvarado ME: Morphological phenotypes in neoplastic progression of human breast epithelial cells. J Submicrosc Cytol Pathol 32: 83-96, 2000.
37. Calaf G, Russo J and Alvarado ME: Morphological phenotypes in neoplastic progression of benz(a)alpha pyrene-treated breast epithelial cells. J Submicrosc Cytol Pathol 32: 535-545, 2001.
38. Soule HD, Vazquez J, Long A, Albert S and Brennan MA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
39. Gross-Bellard M, Oudet P and Chambon P: Isolation of high-molecular- weight DNA from mammalian cells. Eur J Biochem 36: 32-38, 1973.
40. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, 1989.
41. Jaeckel S, Epplen JT, Kauth M, Miterski B, Tschentscher F and Epplen C: Polymerase chain reaction-single strand conformation polymorphism or how to detect reliably and efficiently each sequence variation in many samples and many genes. Electrophoresis 19: 3055-3061, 1998.
42. Chudoba I, Plesch A, Lorch T, Lemke J, Claussen U and Senger G: High resolution multicolor-banding: a new technique for refined FISH analysis of human chromosomes. Cytogenet Cell Genet 84: 156-160, 1999.
43. Eils R, Uhrig S, Saracoglu K, Satzler K, Bolzer A, Petersen I, Chassery JM, Ganser M and Speicher MR: An optimized fully automated system for fast and accurate identification of chromosomal rearrangements by multiplex-FISH (MFISH). Cytogenet Cell Genet 82: 160-171, 1998.
44. Savage JR and Simpson PJ: FISH 'painting' patterns resulting from complex exchanges. Mutat Res 312: 51-60, 1994.
45. Bieche I and Lidereau R: Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227-251, 1995.
46. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, De la Chapelle A, Kinzler KW, Vogelstein B and Modrich P: Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227-1236, 1993.
47. Dedhar S: Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 12: 250-256, 2000.
48. Nagahata T, Hirano A, Utada Y, Tsuchiya S, Takahashi K, Tada T, Makita M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y and Emi M: Correlation of allelic losses and clinico-pathological factors in 504 primary breast cancers. Breast Cancer 9: 208-215, 2002.
49. Gentile M, Ahnstrom M, Schon F and Wingren S: Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53 induced apoptosis. Oncogene 20: 7753-7760, 2001.
50. Saxon PJ, Srivatsan ES and Stanbridge EJ: Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 5: 3461-3466, 1986.
51. Pui CH, Chessells JM, Camitta B, et al: Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 17: 700-706, 2003.
52. Launonen V, Stenback F, Puistola U, Bloigu R, Huusko P, Kytola S, Kauppila A and Winqvist R: Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions. Gynecol Oncol 71: 299-304, 1998.
53. Dahiya R, McCarville J, Lee C, Hu W, Kaur G, Carroll P and Deng G: Delection of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int J Cancer 72: 283-288, 1997.
54. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, Moch H, Mihatsch MJ, Gasser TC and Sauter G: Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 59: 5687-5691, 1999.
55. Baysal BE, Willett-Brozick JE, Taschner PE, Dauwerse JG, Devilee P and Devlin B: A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region. Eur J Hum Genet 9: 121-129, 2001.
56. Martin ES, Cesari R, Pentimalli F, Yoder K, Fishel R, Himelstein AL, Martin SE, Godwin AK, Negrini M and Croce CM: The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci USA 100: 11517-11522, 2003.
57. Laake K, Odegard A, Andersen TI, Bukholm IK, Karesen R, Nesland JM, Ottestad L, Shiloh Y and Borresen-Dale AL: Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18: 175-180, 1997.
58. Ounap K, Bartsch O, Uibo O and Laidre P: Girl with combined immunodeficiency, pancytopenia, malformations, deletion 11q23.3→qter, and trisomy 8q24.3→qter. Am J Med Genet 108: 322-326, 2002.